Women are a major force in the healthcare sector. Can this strong participation open the doors to wider leadership?
Danish pharma giant Novo Nordisk’s recent launch of Ozempic in India alongside a 37% price cut on Wegovy points out at more than a market entry. It reflects a strategic recalibration as semaglutide ap...
The path to the top is rarely smooth, but Lupin's Vinita Gupta says women leaders must lead with conviction and a global mindset
Emil Kongshøj Larsen, Executive Vice President for International Operations at Novo Nordisk, talks to BT about India’s role in the company’s growth plans.
Madhurima Singh's rise to the top has been underpinned by an insatiable appetite for learning, pursuit of excellence.
Ameera Shah said the professional journey for women still involves dealing with visible and predictable blocks of time away from work, which organisations seldom plan for
The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes
Novo Nordisk has launched Ozempic, its once-weekly semaglutide injection for adults with type 2 diabetes, in the Indian market. The GLP-1 therapy, already widely used globally, offers blood-sugar con...
Servier India has received approval for Vorasidenib (Voranigo), adding a second rare-cancer treatment to its portfolio in the country. The targeted IDH inhibitor offers an option for patients with Gra...
Servier India to launch Vorasidenib (Voranigo), a targeted therapy for patients with Grade 2 IDH-mutant glioma
Bondi Beach Mass Shooting Explained: How Did It Happen Despite Australia’s Strict Gun Laws?
National Herald Case Explained: Court Relief For Gandhis, ED Pushes Back In High-Stakes Probe
Oneweb 2027 Plans: New Tech, New Features
Vinit Bolinjkar's 2026 Market Strategy: Be Selective And Valuation-Driven
Accenture Results Spark Fresh Buzz In IT, Early Turn Or Just A Bounce?
